Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, Matthew Carter, Ananya Choudhury, Alexandra Clipson, Omar Din, Caroline Dive, Alexandra Gilbert, Sean Girvan, Mohan Hingorani, Suneil Jain, Vincent Khoo, John Lilley, Louise J MurraySee the full list of authors
26 December 2024
TOURISM study (Treatment Outcomes in UteRIne SarcoMa): a 10-year retrospective evaluation of practice in the UKKaren E Mactier, Mark A Baxter, Adam L Peters, Katherine Fair, Laura Hannington, James Robertson, Georgina E Wood, Asma Sarwar, Mai K Bishr, Rebekah Webb, Mohammed Al-Zubaidi, Leonie Eastlake, Katharine Lankester, Samuel McInerney, Helen CreedonSee the full list of authors
26 December 2024
Efficacy of opioid combination versus single opioid for adult cancer pain: a protocol for systematic review and meta-analysisChi Hoon Maeng, David Hui, Ji-Yeon Kang, Soo Young Kim, Jung Hye Kwon
23 December 2024
Understanding cervical cancer prevention in Africa: a qualitative systematic review of the role of menNancy Innocentia Ebu Enyan, Aigli Raouna, Michelle King-Okoye, Sebastian Ken-Amoah, Patrick Kafui Akakpo, Lawrence Doi, Dorcas Obiri-Yeboah
23 December 2024
The MyLungHealth study protocol: a pragmatic patient-randomised controlled trial to evaluate a patient-centred, electronic health record-integrated intervention to enhance lung cancer screening in primary carePolina Kukhareva, Christian Balbin, Elizabeth Stevens, Devin Mann, Victoria Tiase, Jorie Butler, Guilherme Del Fiol, Tanner Caverly, Kim Kaphingst, Chelsey R Schlechter, Angela Fagerlin, Haojia Li, Yue Zhang, Rachel Hess, Michael FlynnSee the full list of authors
22 December 2024
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancerUma Anne Mukherjee, Helen Hockings, Nicholas Counsell, Apini Patel, Priya Narayanan, Katie Wilkinson, Harjot Dhanda, Kathy Robinson, Iain McNeish, Alexander R A Anderson, Rowan Miller, Charlie Gourley, Trevor Graham, Michelle Lockley
22 December 2024
Risk factors and prediction model of breast cancer-related lymphoedema in a Chinese cancer centre: a prospective cohort study protocolAomei Shen, Jingming Ye, Hongmei Zhao, Wanmin Qiang, Hongmeng Zhao, Yubei Huang, Yujie Zhou, Yue Wang, Xin Li, Zhongning Zhang, Jingru Bian, Liyuan Zhang, Peipei Wu, Ying Wang, Qian Lu
20 December 2024
Incidence of cancer-related lymphoedema: a protocol for a living systematic review with meta-analysisMelanie Plinsinga, Ben Singh, Kira Bloomquist, Michael Bernas, Debbie Geyer, Nele Devoogdt, Louise Koelmeyer, Neil Piller, Hildegard Reul-Hirche, Stanley Rockson, Sandi Hayes
20 December 2024
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, David Elder, Peter M Ferguson, Richard A Scolyer, Blake O'Brien, Raymond Barnhill, Adewole S Adamson, Alexander C J van Akkooi, Jon Emery, Lisa Parker, Donald Low, Cynthia Low, Elspeth DaviesSee the full list of authors
20 December 2024
Thoracic perfusion of antiangiogenic agents combined with chemotherapy for treating malignant pleural effusion in non-small cell lung cancer: a network meta-analysisYan Xu, Yingying Cui, Liming Jiang, Yinan Yu, Wei Si, Xiaohua Zhu
20 December 2024
